AstraZeneca (AstraZeneca) Total Stockholders Equity : $37,445 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Total Stockholders Equity?

AstraZeneca's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $37,445 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. AstraZeneca's Book Value per Share for the quarter that ended in Mar. 2024 was $12.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. AstraZeneca's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.92.

AstraZeneca Total Stockholders Equity Historical Data

The historical data trend for AstraZeneca's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Total Stockholders Equity Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

13,127.00

15,622.00

39,268.00

37,037.00

39,143.00

AstraZeneca Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															35,789.00	37,392.00	37,197.00	39,143.00	37,445.00

AstraZeneca (NAS:AZN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

AstraZeneca's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(37445	-	0)	/	3120.000
	=	12.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

AstraZeneca's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6331	+	28220)	/	37445
	=	0.92

AstraZeneca Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.